Loading...
NPI 1285827527 · Bangor, ME · Methadone Clinic
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Discovery House Br, Inc. is a methadone clinic provider located in Bangor, Maine. This profile covers 5 Medicare and 13 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Discovery House Br, Inc. |
| Address | 689 Odlin Rd. |
| City | Bangor |
| State | ME |
| ZIP | 04401 |
| Taxonomy | Methadone Clinic |
| NPI Enumerated | August 21, 2007 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $20.6M |
| Medicare | $527.6K |
DISCOVERY HOUSE BR, INC. operates as an opioid treatment program (Methadone Clinic) with billing dominated by methadone administration and medication-assisted treatment bundles; the code mix (H0020, G2067, G2074, J0574, G2078) shows a primary focus on dispensing methadone, weekly MAT bundles, take-home supplies, and adjunctive counseling/assessment services rather than broad outpatient medical care. This operational profile is consistent with the provider’s specialty taxonomy and the high claim counts reported for drug-administration and MAT bundle codes.
Medicaid revenue is highly concentrated: the provider reports Total Medicaid revenue of $20.6M and the precomputed top 3 Medicaid codes account for 96.6% of that Medicaid revenue. H0020 alone accounts for 188.9K claims and $19.3M revenue (93.2% of Medicaid revenue), indicating almost all Medicaid dollars flow through methadone administration by a licensed program.
Medicare revenue is similarly concentrated in OTP-specific bundles: Total Medicare revenue is $527.6K and the precomputed top 3 Medicare codes account for 98.2% of that Medicare revenue. G2067 drives the majority of Medicare billing with 1.8K claims and $398K revenue (75.3% of Medicare revenue), while G2078 (1.6K claims, $61K, 11.5%) and G2074 (333 claims, $60.3K, 11.4%) complete the concentrated Medicare mix.
Payer mix is sharply skewed toward Medicaid: the provider’s Medicaid revenue ($20.6M) dwarfs its Medicare revenue ($527.6K), making DISCOVERY HOUSE effectively a Medicaid-focused MAT provider in scale and financial dependence. Medicare appears to be a minor payer by dollars, supporting a smaller proportion of bundled MAT encounters compared with Medicaid.
Within the Maine Medicaid market the practice is a leading methadone dispenser: H0020 ranks #2 of 14 providers in-state (92nd percentile), signaling a major in-state position for methadone administration volumes and revenue. Additionally, Medicaid reporting shows G2074 ranks #1 of 5 in-state at the 100th percentile and is described as notably above typical state volume, highlighting an area where this provider bills substantially more than most peers for the non-drug weekly MAT bundle.
On the Medicare side the provider’s national standing is mixed by code: G2067 ranks #96 of 830 providers (89th percentile) and is characterized as a typical, unremarkable volume for that national cohort, while G2078 ranks #19 of 493 providers (96th percentile), indicating relatively high national take-home supply activity for that specific code. Overall, Medicare volumes are meaningful for a narrow set of OTP codes but do not indicate broad national dominance outside those bundles.
Billing for wraparound services is present but small relative to drug administration: Medicaid-level T2022 case management (1.3K claims, $456.9K, 2.2% of Medicaid revenue), H0004 counseling (3.2K claims, $130.9K, 0.6%), H2010 medication services (2.7K claims, $126.1K, 0.6%), and 99408 screening/intervention (742 claims, $122.4K, 0.6%) show the provider delivers ancillary counseling, medication management, and case management alongside dispensing. These non-drug services represent complementary care lines but collectively account for a small share of Medicaid revenue versus H0020.
The provider has an established operational tenure with NPI enumeration on 2007-08-21 (~19 years ago), suggesting long-standing service availability in the local market and sustained billing patterns focused on methadone administration and associated MAT bundles. This longevity, combined with the concentrated revenue mix, points to a stable, specialty-focused business model rather than recent diversification into other outpatient lines.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
5 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| G2067 | Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed… | 1,760 | $230 | $398K |
| G2078 | Take-home supply of methadone; up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure | 1,610 | $40 | $61K |
| G2074 | Medication assisted treatment, weekly bundle not including the drug, including substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services… | 330 | $180 | $60.3K |
| G2077 | Periodic assessment; assessing periodically by an otp practitioner and includes a review of moud dosing, treatment response, other substance use disorder treatment needs, responses and… | 60 | $100 | $6.3K |
| G2076 | Intake activities, including initial medical examination that is conducted by an appropriately licensed practitioner and preparation of a care plan, which may be informed by administration of a… | 20 | $140 | $3.2K |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 5 CPT/HCPCS codes.
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
13 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| H0020 | Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) | 188,920 | $100 | $19.3M |
| T2022 | Case management, per month | 1,290 | $360 | $456.9K |
| J0574 | Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine | 25,650 | $10 | $230.9K |
| G2067 | Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed… | 12,180 | $10 | $158.3K |
| H0004 | Behavioral health counseling and therapy, per 15 minutes | 3,190 | $40 | $130.9K |
| H2010 | Comprehensive medication services, per 15 minutes | 2,680 | $50 | $126.1K |
| 99408 | The provider spends 15 to 30 minutes screening a patient for abuse of alcohol or another non–tobacco substance. The provider then performs a brief intervention at the same session. | 740 | $170 | $122.4K |
| H0047 | Alcohol and/or other drug abuse services, not otherwise specified | 740 | $120 | $89K |
| J0572 | Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine | 9,570 | $10 | $47.9K |
| G2078 | Take-home supply of methadone; up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure | 6,430 | $1 | $19.3K |
Showing 1–10 of 13
How this provider's Medicaid billing volume and revenue compare to other Maine providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Maine median
13 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| H0020 | Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) | 2 | 10 | 61,180 | $110 | $9.2M |
| H2010 | Comprehensive medication services, per 15 minutes | 27 | 50 | 3,690 | $130 | $1.6M |
| H0004 | Behavioral health counseling and therapy, per 15 minutes | 94 | 290 | 860 | $80 | $805.1K |
| T2022 | Case management, per month | 14 | 40 | 800 | $190 | $780.3K |
| H0047 | Alcohol and/or other drug abuse services, not otherwise specified | 14 | 30 | 750 | $240 | $312.9K |
| 99408 | The provider spends 15 to 30 minutes screening a patient for abuse of alcohol or another non–tobacco substance. The provider then performs a brief intervention at the same session. | 13 | 30 | 740 | $240 | $301.1K |
| J0574 | Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine | 2 | 10 | 20,880 | $10 | $236.2K |
| G2067 | Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed… | 3 | 10 | 5,260 | $10 | $78.6K |
| J0572 | Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine | 1 | 10 | 3,170 | $1 | $25.6K |
| G2078 | Take-home supply of methadone; up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure | 2 | 10 | 950 | $1 | $6.5K |
Showing 1–10 of 13
Other providers in the same ZIP code as Discovery House Br, Inc., ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.